Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00332488
Status:
COMPLETED
Last Update Posted:
2014-10-16
First Post:
2006-05-31
Brief Title:
Efficacy and Safety of Prandial Inhalation of TechnosphereInsulin in Combination With Metformin or TechnosphereInsulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes
Sponsor:
Mannkind Corporation
Organization:
Mannkind Corporation
Study Overview
Official Title:
A Phase 3 24-Week Multi-Center Open-Label Randomized Controlled Trial Comparing the Efficacy and Safety of Prandial Inhalation of TechnosphereInsulin in Combination With Metformin or TechnosphereInsulin Alone Versus 2 Oral Anti-Diabetic Agents Metformin and a Secretagogue in Subjects With Type 2 Diabetes Mellitus Sub-optimally Controlled on Combination Metformin and a Secretagogue
Status:
COMPLETED
Status Verified Date:
2014-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
to demonstrate the efficacy of inhaled TechnosphereInsulin in combination with metformin versus combination metformin and a secretagogue
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None